Evaluation of The Effect of Bupivacaine (Marcaine) in Reducing Early Post Tonsillectomy Pain

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Research Methodology:

It will be a prospective, randomized, placebo-controlled, single-blind, intra-individual study in which one tonsillar fossa will be the tested side, and the other fossa will be the control. And the tested side will be packed with bupivacaine for five minutes. In the other hand, the controlled side will be packed for five minutes with gauze soaked in normal saline. The selection of the tested side and controlled side will be randomized based on the last digit in the medical record number (i.e. if the last digit is even then the tested side is the right and if the last digit is odd then the tested side is the left). Pain evaluation will be by visual analog scale and it will be in frequency of 2, 4, 6, 8, 12, 24 hours post-op.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Saud University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• all patients undergoing tonsillectomy

Exclusion Criteria:

1. pt with past history of unilateral peritonsillar abscess

2. the current, regular use of a systemic steroid or NSAID

3. a known hypersensitivity to bupivacaine

4. a combined with unilateral myringotomy or bilateral myringotomy with unilateral ventilation tube

5. pt with poor dental hygiene